Sector research log

Healthcare & Pharma/Biotech Stocks: Insider Trading and Market Alerts

Every event InsiderWatch has flagged in the healthcare & pharma/biotech sector: insider buys, stake filings, policy moves and market events, with the stocks involved and when each went out. Listed after a short delay.

Stocks with healthcare & pharma/biotech alerts

• $ABBV×5
• $LLY×5
• $SMMT×4
• $AZN×3
• $BNTX×3
• $COO×3
• $IONS×3
• $NVO×3
• $NVS×3
• $AMGN×2
• $BRVE×2
• $BSX×2
• $ENOV×2
• $GSK×2
• $HELP×2
• $ICLR×2
• $MED×2
• $MRK×2
• $PFE×2
• $PLSE×2
• $PRTA×2
• $SLGL×2
• $TENX×2
• $ABCL
• $ABT
• $ACB
• $ADPT
• $ADRX
• $ALMS
• $ASND
• $ASTH
• $ATEC
• $AVAH
• $BMRN
• $CAH
• $CTEV
• $CURLF
• $DMRA
• $EIKN
• $ELAN
• $FLNA
• $GDRX
• $GH
• $GILD
• $GPCR
• $HALO
• $IMCC
• $IMTX
• $IMVT
• $INBX
• $IRON
• $KOD
• $KURA
• $LYNX
• $MEDP
• $MIR
• $MRNA
• $NAMS
• $OBX
• $OCS

Latest healthcare & pharma/biotech events

The 25 most recent, with the call as it was sent.

Healthcare & Pharma/Biotech events, newest first

Date	Stock	Alert	Call
Nov 4, 2026	$ICLR	ICON CEO, CFO and director sell $2.1M after rallyInsider sell cluster	BEARISH
Nov 3, 2026	$OCS	Oculis moves to raise cash through a stock saleOffering / dilution	BEARISH
Nov 2, 2026	$GDRX	GoodRx warns past financial statements cannot be relied onDistress / delisting	BEARISH
Nov 2, 2026	$BSX	Boston Scientific WATCHMAN study meets primary endpointsMarket event	BULLISH
Oct 30, 2026	$VOR	Vor Biopharma moves to sell new stockOffering / dilution	BEARISH
Oct 28, 2026	$LLY	Lilly's retatrutide beats Ozempic in head-to-head Phase 3Market event	BULLISH
Oct 27, 2026	$RAPP	Rapport Therapeutics taps market after upbeat bipolar dataOffering / dilution	BEARISH
Oct 27, 2026	$PFE	Pfizer myeloma drug wins Phase 3 trialMarket event	BULLISH
Oct 26, 2026	$AMGN	Roche lung-cancer drug beats rivals on survival in Phase 3Market event	BULLISH
Oct 22, 2026	$RCUS	Arcus Biosciences moves to raise cash by selling stockOffering / dilution	BEARISH
Oct 22, 2026	$ABBV	AbbVie skin-disease drug succeeds in late-stage trialMarket event	BULLISH
Oct 21, 2026	$QGEN	EQT agrees all-cash takeover of QIAGENM&A target	BULLISH
Oct 20, 2026	$GSK	FDA approves first-of-its-kind hepatitis B drug HibsagoMarket event	BULLISH
Oct 20, 2026	$IRON	Disc Medicine sells new stock after rare-disease rallyOffering / dilution	BEARISH
Oct 16, 2026	$VTRS	Viatris wins FDA approval for presbyopia eye dropMarket event	BULLISH
Oct 15, 2026	$RXRX	Recursion files to sell stock, diluting shareholdersOffering / dilution	BEARISH
Oct 13, 2026	$BNTX	BioNTech head and neck cancer vaccine misses key endpointMarket event	BEARISH
Oct 5, 2026	$SYRE	Spyre Therapeutics moves to raise cash with new sharesOffering / dilution	BEARISH
Sep 30, 2026	$ADRX	ADARx insiders buy $87.7M of stock after IPOInsider buy	BULLISH
Sep 30, 2026	$KOD	Baker Bros. buys $58.6M of Kodiak after data surgeInsider buy	BULLISH
Sep 30, 2026	$FLNA	Filana CEO buys $78K of his own stockInsider buy	BULLISH
Sep 28, 2026	$ABBV	FDA approves AbbVie's Parkinson's drug JUVMOMarket event	BULLISH
Sep 28, 2026	$DMRA	Damora CEO buys $253K of beaten-down stockInsider buy	BULLISH
Sep 24, 2026	$IMVT	Immunovant lupus drug hits setbackMarket event	BEARISH
Sep 24, 2026	$MRK	Merck eye drug hits goal in pivotal DME trialMarket event	BULLISH

Sector tags are assigned per alert by the analysis step, so a stock can appear in more than one sector. The call shown is a reading of the event, not investment advice. More in the research log.